WallStreetZenWallStreetZen

NASDAQ: MNPR
Monopar Therapeutics Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Monopar Therapeutics earnings were -$16.6M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest MNPR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.6M, down 76% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MNPR reported annual earnings of -$15.6M, with 85.5% growth.

MNPR earnings history

Current Revenue
$0.0
Current Earnings
-$16.6M
Current Profit Margin
0%

MNPR Return on Equity

Current Company
-55.4%
Current Industry
-60.2%
Current Market
31.5%
MNPR's Return on Equity (-55.4%)... subscribe to Premium to read more.
High Return on Equity Performance

MNPR undefined

Current Company
-51.5%
Current Industry
-2.5%
MNPR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MNPR announces earnings.

MNPR undefined

Current Company
-30.92%
Current Industry
5.8%
MNPR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MNPR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MNPR-$16.57M-$16.57MN/A-$4.00
GNFT$9.48M$1.71M-99.39%$0.03
KOD-$163.84M-$190.63MN/A-$3.63
FDMT-$169.57M-$176.44MN/A-$3.18
IMABN/A-$7.58MN/A-$0.12
View Top Biotech Stocks

Monopar Therapeutics Earnings Reports & History FAQ

What were Monopar Therapeutics's earnings last quarter?

On MNPR's earnings call on Invalid Date, Monopar Therapeutics (NASDAQ: MNPR) reported Q1 2025 earnings per share (EPS) of -$0.38, up 25.49% year over year. Total MNPR earnings for the quarter were -$2.62 million. In the same quarter last year, Monopar Therapeutics's earnings per share (EPS) was -$0.51.

If you're new to stock investing, here's how to buy Monopar Therapeutics stock.

Is Monopar Therapeutics profitable or losing money?

As of the last Monopar Therapeutics earnings report, Monopar Therapeutics is currently losing money. Monopar Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$16.57 million, a 117.77% increase year over year.

What was MNPR's earnings growth in the past year?

As of Monopar Therapeutics's earnings date in Invalid Date, Monopar Therapeutics's earnings has grown year over year. MNPR earnings in the past year totalled -$16.57 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.